期刊文献+

甲氰咪胍佐治小儿过敏性紫癜疗效观察 被引量:2

在线阅读 下载PDF
导出
摘要 目的观察甲氰咪胍治疗小儿过敏性紫癜的疗效。方法55例过敏性紫癜患儿随机分为两组。治疗组(28例)在对照组(27例)常规治疗基础上加用甲氰咪胍10—20mg/(kg·d),分两次静滴,连续2用。结果治疗组显效率78.6%,总有效率92.9%,对照组显效率51.9%,总有效率70.4%,两组之间显效率及总有效率比较,P〈0.05,有显著性差异。结论甲氰咪胍治疗小儿过敏性紫痘疗效确切。不良反应小,值得临床推广。
作者 包克珍
出处 《西南军医》 2006年第6期41-41,共1页 Journal of Military Surgeon in Southwest China
  • 相关文献

参考文献2

二级参考文献20

  • 1符仁义,盛先锋,向承发,廖清奎.西咪替丁治疗过敏性紫癜临床观察[J].中华儿科杂志,1995,33(2):111-112. 被引量:88
  • 2任线平,吕世英.异体光量子血疗法防治儿童紫癜性肾炎:附20例报告[J].临床儿科杂志,1996,14(1):34-34. 被引量:5
  • 3王黎玲.小剂量免疫球蛋白治疗难治性过敏性紫癜[J].实用儿科临床杂志,1998,13(4):248-249.
  • 4Pasatiempo AMG, Kroser JA, Rudnick M, et al. Acute renal failure after intravenous immunoglobulin therapy.J Rheumtol, 1994, 21 : 347- 349.
  • 5Blanco R, Gonzalez-Gay MA, Ibanez D, et al. Paradoxical and persistent renal impairment in Henoch-Schōnlein purpura after high-dose immunoglubin therapy.Nephron, 1997, 76 :247- 248.
  • 6Meulders Q, Pirson Y, Cosyns JP, et al. Course of Henoch-Schōnlein nephritis after renal transplantation. Transplantation, 1994, 58 : 1179 - 1186.
  • 7Tm Barratt, ED Arner, WE harmon. Pediatric nephrology, 4th ed. Baltimore: Lippincontt, Williams & Wilkins, 1999 : 691 -
  • 8Saulsbury FT. Henoch-Sch6nlein purpura in children:Report of 100 patient and review of literature.Medicine(Baltimore),1999,78(6) : 395- 409.
  • 9Flynn JT, Smoyer WE, Bunchaman TE, et aI.Treatment of Henoch-Sch6nlein purpura glomerulonephritis in children with high-do6e corticosteroids plus oral cyclophosphamide.Am J Nephrol, 2001, 21(2) : 128- 133.
  • 10Niaudet P, Habib K. Methylprednisolone pulse therapy in the treatment of severe forms of Schōnlein-Henoch purpura nephritis, Pediatr Nephrol, 1998, 12(3) : 238- 243.

共引文献90

同被引文献23

  • 1贾艳红.甲氰咪胍在儿科的临床应用[J].中国社区医师(医学专业),2004,6(8):6-6. 被引量:1
  • 2鲁珊,叶鸿瑁,李国权,张晶明.1~6岁健康儿105名心肌酶谱检测与分析[J].中国儿童保健杂志,2004,12(6):532-533. 被引量:20
  • 3孙传法.甲氰咪胍的临床新用途[J].实用医技杂志,2005,12(02B):518-518. 被引量:1
  • 4王军,耿志洲,刘永梅,牛聪敏,陈宇萍.西咪替丁治疗肾综合征出血热的临床研究[J].中国基层医药,2006,13(5):739-740. 被引量:4
  • 5胡亚美,江载芳.诸福棠实用儿科学[M].7版.北京:人民卫生出版社,2002:632-636.
  • 6Goldberger JJ, Cain ME, Hohnloser SH, et al. AHA/ACC/ HRS Scientifie Statement on Noninvesive Risk Stratification Techniques for identifying Patients at Risk for Sudden CardiacDeath[J]. Circulation,2008,11(8) :1497-I518.
  • 7赵日科,刘继新,房芳.西咪替丁治疗胃、十二指肠球部溃疡出现心律失常2例[J],河北医学,2008,12(16):395-396.
  • 8Letsas K, Korantzopoulos P, Pappas L, et al. QT interval prolongation associated with venlafaxine administration[J]. Int J Cardiol,2006,109(1) : 116-117.
  • 9Ueda K, Valdivia C, Medeiros-Domingo A,et,al. Syntrophin mutation associated with long QT syndrome through activation of the nNOS-SCNSA macromolecular complex[J]. Proc Natl Acad Sci USA,2008, 105(15): 9355-9360.
  • 10Malik M, Hnatkova K, Schmidt A,et al. Electrocardiographic QTc changes due to moxifloxacin infusion [ J ]. J Clin Pharmacol, 2009,49(6)674-683.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部